Literature DB >> 24954972

Modeling-error robustness of a viral-load preconditioning strategy for HIV treatment switching.

Rutao Luo1, Michael J Piovoso2, Ryan Zurakowski3.   

Abstract

In previous work, we have developed optimal-control based approaches that seek to minimize the risk of subsequent virological failure by "pre-conditioning" the viral load during therapy switches. In this paper, we use Monte-Carlo methods to evaluate the sensitivity of an open-loop implementation of these approaches to modeling errors. To account for hidden parameter dependencies, we use parameter distributions obtained from the convergence of Bayesian parameter estimation techniques applied to sets of clinical data obtained during serial therapy interruptions as the distribution from which the Monte-Carlo method samples.

Entities:  

Year:  2010        PMID: 24954972      PMCID: PMC4061758          DOI: 10.1109/acc.2010.5530483

Source DB:  PubMed          Journal:  Proc Am Control Conf        ISSN: 0743-1619


  16 in total

1.  Production of resistant HIV mutants during antiretroviral therapy.

Authors:  R M Ribeiro; S Bonhoeffer
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

2.  A new form of antiviral combination therapy predicted to prevent resistance from arising, and a model system to test it.

Authors:  W F Mangel; W J McGrath; M T Brown; M L Baniecki; D L Barnard; Y P Pang
Journal:  Curr Med Chem       Date:  2001-07       Impact factor: 4.530

Review 3.  Antiretroviral therapy : optimal sequencing of therapy to avoid resistance.

Authors:  Jorge L Martinez-Cajas; Mark A Wainberg
Journal:  Drugs       Date:  2008       Impact factor: 9.546

4.  HIV treatment failure: testing for HIV resistance in clinical practice.

Authors:  L Perrin; A Telenti
Journal:  Science       Date:  1998-06-19       Impact factor: 47.728

5.  Pre-existence and emergence of drug resistance in HIV-1 infection.

Authors:  S Bonhoeffer; M A Nowak
Journal:  Proc Biol Sci       Date:  1997-05-22       Impact factor: 5.349

6.  Hierarchical Bayesian methods for estimation of parameters in a longitudinal HIV dynamic system.

Authors:  Yangxin Huang; Dacheng Liu; Hulin Wu
Journal:  Biometrics       Date:  2006-06       Impact factor: 2.571

7.  Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.

Authors:  Scott M Hammer; Michael S Saag; Mauro Schechter; Julio S G Montaner; Robert T Schooley; Donna M Jacobsen; Melanie A Thompson; Charles C J Carpenter; Margaret A Fischl; Brian G Gazzard; Jose M Gatell; Martin S Hirsch; David A Katzenstein; Douglas D Richman; Stefano Vella; Patrick G Yeni; Paul A Volberding
Journal:  JAMA       Date:  2006-08-16       Impact factor: 56.272

8.  Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel.

Authors:  Martin S Hirsch; Françoise Brun-Vézinet; Bonaventura Clotet; Brian Conway; Daniel R Kuritzkes; Richard T D'Aquila; Lisa M Demeter; Scott M Hammer; Victoria A Johnson; Clive Loveday; John W Mellors; Donna M Jacobsen; Douglas D Richman
Journal:  Clin Infect Dis       Date:  2003-06-23       Impact factor: 9.079

9.  Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.

Authors:  Patrick G Yeni; Scott M Hammer; Martin S Hirsch; Michael S Saag; Mauro Schechter; Charles C J Carpenter; Margaret A Fischl; Jose M Gatell; Brian G Gazzard; Donna M Jacobsen; David A Katzenstein; Julio S G Montaner; Douglas D Richman; Robert T Schooley; Melanie A Thompson; Stefano Vella; Paul A Volberding
Journal:  JAMA       Date:  2004-07-14       Impact factor: 56.272

Review 10.  Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.

Authors:  Patrick G Yeni; Scott M Hammer; Charles C J Carpenter; David A Cooper; Margaret A Fischl; Jose M Gatell; Brian G Gazzard; Martin S Hirsch; Donna M Jacobsen; David A Katzenstein; Julio S G Montaner; Douglas D Richman; Michael S Saag; Mauro Schechter; Robert T Schooley; Melanie A Thompson; Stefano Vella; Paul A Volberding
Journal:  JAMA       Date:  2002-07-10       Impact factor: 56.272

View more
  5 in total

1.  Controlling the Evolution of Resistance.

Authors:  Rutao Luo; Lamont Cannon; Jason Hernandez; Michael J Piovoso; Ryan Zurakowski
Journal:  J Process Control       Date:  2011-03-01       Impact factor: 3.666

2.  Robust closed-loop minimal sampling method for HIV therapy switching strategies.

Authors:  E F Cardozo; R Zurakowski
Journal:  IEEE Trans Biomed Eng       Date:  2012-05-25       Impact factor: 4.538

3.  Approximate-model closed-loop minimal sampling method for HIV viral-load minima detection.

Authors:  Ryan Zurakowski; Matthew Churgin; Camilo Perez; Matthew Rodriguez
Journal:  Proc Am Control Conf       Date:  2011

4.  Nonlinear observer output-feedback MPC treatment scheduling for HIV.

Authors:  Ryan Zurakowski
Journal:  Biomed Eng Online       Date:  2011-05-27       Impact factor: 2.819

5.  Optimal antiviral switching to minimize resistance risk in HIV therapy.

Authors:  Rutao Luo; Michael J Piovoso; Javier Martinez-Picado; Ryan Zurakowski
Journal:  PLoS One       Date:  2011-11-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.